Duloxetine versus placebo in the treatment of patients with diabetic peripheral neuropathic pain in China.

Trial Profile

Duloxetine versus placebo in the treatment of patients with diabetic peripheral neuropathic pain in China.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Mar 2011 Primary endpoint 'Pain-measures' has not been met
    • 23 Mar 2011 Primary endpoint 'Brief-Pain-Inventory' has not been met
    • 09 Jun 2009 Actual patient number changed from 214 to 215 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top